Chemical genomics-based antifungal drug discovery

In-vitro activity of F901318 and comparators against clinical isolates of cryptic species of Aspergillus

Ana Alastruey-Izquierdo

2017

Resistance mechanisms to antifungals

David Perlin

2017

A prospective, phase 2, multicentre, open-label, randomized, comparative study to estimate the safety, tolerability, pharmacokinetics, and efficacy of oral SCY-078 vsstandard-of-care following initial intravenous echinocandin therapy in the treatment of..

Peter G. Pappas

2017

Year in infectious disease – Top ten papers

Bart Jan Kullberg

2017

Retrospective observational cohort study comparing the management and outcome of culture-positive invasive aspergillosis due to Aspergillus fumigatus with wildtype and non-wildtype triazole susceptibility

Bram Lestrade

2017

Prevalence and characterization of azole-resistant Aspergillus fumigatus in German CF-patients

Raphael Seufert

2017

Comparison of two molecular assays concerning detection and characterization of Aspergillus fumigatus azole resistance and cyp51A mutations in clinical isolates and primary clinical samples of immunocompromised patients

Birgit Spiess

2017

Unveiling the mechanistic basis underlying Aspergillus fumigatus 5-flucytosine resistance

Fabio Gsaller

2017

Invasive fungal disease in paediatric patients undergoing therapy for a haematological malignancy or receiving allogeneic haematopoietic stem-cell transplantation: an interim analysis of the prospective multicentre study IFI-PED

Thomas Lehrnbecher

2017

Aspergillus infection in patients supported on extracorporeal membrane oxygenation (ECMO).

Isabel Rodriguez Goncer

2017